In The Real World Study, Covaxin shows only 50% efficacy against symptomatic COVID-19:
In the real-world study done by Lancet Infectious Disease, BBV152 or Covaxin Indigenously produced vaccine showed only 50% efficacy against ...
In the real-world study done by Lancet Infectious Disease, BBV152 or Covaxin Indigenously produced vaccine showed only 50% efficacy against ...
Due to non-payment of Salaries for the past two months, Sanitation workers and nursing staff of All India Institute of ...
© 2017-23. The Second Angle. All Rights Reserved. Developed and Managed by SquareBase.io